Interpace Biosciences (IDXG) awards CEO 1.97M RSUs plus stock options
Rhea-AI Filing Summary
INTERPACE BIOSCIENCES, INC. (IDXG) reported equity compensation and related share movements for CEO, President & Chairman Thomas W. Burnell. On August 20, 2026 he was granted 1,966,763 Restricted Stock Units (RSUs), each representing one share of common stock, all of which vested upon grant and included additional RSUs intended to cover tax obligations. These RSUs converted into common stock, and 581,718 shares were returned to the company to satisfy tax withholding obligations, with Burnell receiving the remaining shares. He also received a grant of 554,018 stock options with a strike price of $2.02 per share, vesting in four equal annual installments beginning August 20, 2027 and expiring August 20, 2036. Separately, 10,885 shares of common stock are reported as held indirectly by his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,385,045 shares
Net Buy
6 txns
Insider
Burnell Thomas W.
Role
CEO, President & Chairman
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F3, F4 | 1,966,763 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F3, F4 | 1,966,763 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) F5 | 554,018 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 1,966,763 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F2 | 581,718 | $1.61 | $937K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Stock Option (right to buy) — 554,018 shares (Direct);
Common Stock — 1,455,927 shares (Direct);
Common Stock — 10,885 shares (Indirect, By spouse)
Footnotes (5)
- F1. Represents the conversion upon vesting of restricted stock units ("RSUs") into shares of common stock of Interpace Biosciences, Inc. (the "Issuer"). On August20, 2026, the Reporting Person was granted 1,966,763 RSUs, all of which vested upon grant and which amount includes an amount intended to satisfy the Reporting Person's tax obligations arising from the award.
- F2. Represents shares returned to the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person received the net number of shares after the shares were returned to the Issuer to satisfy applicable tax withholding obligations.
- F3. Each RSU represents a contingent right to receive the economic equivalent of one share of common stock of Interpace Biosciences, Inc.
- F4. On August 20, 2026, the Reporting Person was granted 1,966,763 RSUs, all of which vested upon grant and which amount includes an amount intended to satisfy the Reporting Person's tax obligations arising from the award.
- F5. The options will vest in four equal annual installments beginning on August 20, 2027, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
RSUs granted: 1,966,763 RSUs
Shares returned for tax withholding: 581,718 shares
Stock options granted: 554,018 options
+3 more
6 metrics
RSUs granted
1,966,763 RSUs
Granted to Thomas W. Burnell on August 20, 2026; all vested upon grant
Shares returned for tax withholding
581,718 shares
Returned to issuer to satisfy tax withholding on RSU vesting
Stock options granted
554,018 options
Grant to Thomas W. Burnell on August 20, 2026
Option exercise price
$2.02 per share
Exercise price for 554,018 stock options granted August 20, 2026
Option expiration date
August 20, 2036
Expiration of stock options granted to Thomas W. Burnell
Indirect common stock holdings
10,885 shares
Common stock held indirectly by spouse
Key Terms
Restricted Stock Units, Stock Option (right to buy), tax withholding obligations, contingent right
4 terms
Restricted Stock Units financial
"On August 20, 2026, the Reporting Person was granted 1,966,763 RSUs"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"The options will vest in four equal annual installments"
tax withholding obligations financial
"shares returned to the Issuer to satisfy tax withholding obligations"
contingent right financial
"Each RSU represents a contingent right to receive the economic equivalent"
FAQ
What RSU award did IDXG grant to CEO Thomas W. Burnell on August 20, 2026?
Thomas W. Burnell received 1,966,763 RSUs on August 20, 2026. All RSUs vested upon grant and the amount includes RSUs intended to satisfy his tax obligations arising from the award, each RSU representing one share of Interpace Biosciences common stock.
What stock options did IDXG grant to Thomas W. Burnell in this Form 4?
Thomas W. Burnell was granted 554,018 stock options with an exercise price of $2.02 per share. These options vest in four equal annual installments beginning on August 20, 2027, subject to his continued service, and expire on August 20, 2036.
Were the RSUs for IDXG fully vested when granted to Thomas W. Burnell?
Yes. The filing states that the 1,966,763 RSUs granted to Thomas W. Burnell on August 20, 2026 all vested upon grant, and the amount includes RSUs intended to cover tax obligations related to the award.
AI-generated analysis. How Rhea-AI works. Not financial advice.
